 |
市场调查报告书
商品编码
1673009
丛集性头痛市场：按类型、药物类型、给药途径、分销管道和地区划分Cluster Headache Market, By Type, By Drug Type, By Route of Administration, By Distribution Channel, By Geography |
||||||
价格
简介目录
2025 年全球丛集性头痛市场规模估计为 4.493 亿美元，预计到 2032 年将达到 6.94 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 6.4%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025 年市场规模 | 4.493亿美元 |
| 效能资料 | 2020-2024 | 预测期 | 2025-2032 |
| 预测期：2025 年至 2032 年复合年增长率 | 6.40% | 2032 年金额预测 | 6.94亿美元 |
数字。 2025 年丛集性头痛市场占有率（按地区划分）
丛集性头痛是一种神经系统疾病，其特征是连续发作的严重头痛，每次持续 15 至 180 分钟。它常常影响头部的一侧，导致眼睛和太阳穴周围剧烈疼痛。确切原因尚不清楚，但可能的诱因包括饮酒、失眠、过敏和睡眠模式改变。据估计，全世界约有 0.1% 的人口（约 300 万人）受到影响。男女比例为3：1，男性患病人数多于女性。它通常发生在20至50岁之间。虽然不会危及生命，但剧烈的疼痛会严重影响生活品质。治疗方案包括急性治疗，例如氧气疗法和曲坦类药物以缓解症状，以及预防性治疗，例如维拉帕米以减少发作的频率和强度。预计在不久的将来，对症状管理的认识的提高和医疗保健支出的增加将推动全球丛集性头痛市场的成长。
市场动态
全球丛集性头痛市场的成长得益于诊断率的上升以及人们对该病症及其治疗的认识的提高。根据2020年全球流行病学研究，由于患者和医师缺乏认识，丛集性头痛常被误诊。但非营利组织日益增多的医学教育倡议正在帮助提高诊断率。预计这将推动对急性和预防治疗方案的需求。此外，新兴国家医疗保健支出的增加也将推动市场的发展。然而，高昂的治疗成本（尤其是在新兴经济体）可能会阻碍市场成长。核准学名药的短缺导致治疗成本增加。在预测期内，持续研究和开发有效且经济实惠的治疗方案可以为市场参与企业提供新的机会。
研究的主要特点
- 本报告对全球丛集性头痛市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。
- 它还强调了各个领域的潜在商机并说明了该市场的有吸引力的投资提案矩阵。
- 它还提供了关于市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的主要考察。
- 它根据公司亮点、产品系列、关键亮点、业绩和策略等参数列出了全球丛集性头痛市场的主要企业简介。
- 本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
- 全球丛集性头痛市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
- 相关人员将透过全球丛集性头痛市场分析中使用的各种策略矩阵更轻鬆地做出决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
- 一致的机会图 (COM)
第三章市场动态、法规与趋势分析
- 市场动态
- 驱动程式
- 限制因素
- 机会
- 影响分析
- 市场趋势
- 监管情景
- 收购和合作场景
- 资金筹措和投资
- PEST分析
- 波特的分析
4. 全球丛集性头痛市场-冠状病毒 (COVID-19) 大流行的影响
- 整体影响
- 政府倡议
- COVID-19 市场影响
5. 2020 年至 2032 年全球丛集性头痛市场（按类型划分）（百万美元）
- 介绍
- 阵发性
- 慢性的
6. 2020-2032 年全球丛集性头痛市场（按药物类型划分）（百万美元）
- 介绍
- 速效药物
- 长期服药
- 短期用药
7. 2020 年至 2032 年全球丛集性头痛市场，依给药途径划分（百万美元）
- 介绍
- 口服
- 局部的
- 静脉
- 其他的
8. 2020-2032 年全球丛集性头痛市场按分销管道划分（百万美元）
- 介绍
- 医院药房
- 零售药局
- 网路药局
9. 2020 年至 2032 年全球丛集性头痛市场（按地区划分）（百万美元）
- 介绍
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第十章 竞争格局
- 公司简介
- Autonomic Technologies, Inc.
- Epic Systems Corporation
- AstraZeneca
- ElectroCore, Inc.
- Eli Lilly and Company
- Hoffmann-La Roche Ltd
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- WL Gore &Associates, Inc.
- Zosano Pharma
- Allergan, plc
- Amgen Inc.
- Biohaven Pharmaceutical Holding Company Ltd.
- Cefaly Technology
- Eliem Therapeutics, Inc.
- Lundbeck Seattle BioPharmaceuticals, Inc.
- Prismic Pharmaceuticals, Inc.
- Sanofi
- Upsher-Smith Laboratories, LLC
第 11 章 分析师建议
- 兴衰
- 一致的机会地图
第 12 章参考文献与调查方法
- 参考
- 调查方法
简介目录
Product Code: CMI4709
Global Cluster Headache Market is estimated to be valued at USD 449.3 Mn in 2025 and is expected to reach USD 694.0 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.4% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 449.3 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.40% | 2032 Value Projection: | USD 694.0 Mn |
Figure. Cluster Headache Market Share (%), By Region 2025
Cluster headache is a neurological condition characterized by severe headaches occurring in clusters with each headache lasting 15-180 minutes. It often affects one side of the head and causes excruciating pain around the eye and temple. The exact cause remains unknown but some potential triggers include alcohol consumption, insomnia, allergies, and changes in sleeping patterns among others. It is estimated to affect around 0.1% of the general population worldwide or roughly 3 million people. Men are affected more than women with a male to female ratio of 3:1. It usually develops between the ages of 20-50. While it is not life-threatening, the intense pain severely affects quality of life. Treatment options include acute therapies like oxygen and triptans for symptom relief and preventive therapies like verapamil to reduce the frequency and intensity of attacks. Growing awareness about condition management and rising healthcare expenditure are expected to drive the global cluster headache market growth in the near future.
Market Dynamics:
Global cluster headache market growth is driven by increasing diagnosis rate and growing awareness about the condition and its management. According to a Global Epidemiology Study in 2020, cluster headache is often underdiagnosed due to lack of awareness in both patients and physicians. However, growing medical education initiatives by non-profit organizations help to improve diagnosis rate. This is expected to boost demand for acute and preventive treatment options. Furthermore, rising healthcare spending in developing countries can also drive the market growth. However, high treatment cost, especially in developing economies, can hamper the market growth. Lack of approved generic drugs increases treatment cost. Ongoing R&D for effective and affordable treatment options can provide new opportunities for market participants over the forecast period.
Key features of the study:
- This report provides in-depth analysis of the global cluster headache market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cluster headache market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Eli Lilly and Company, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries, TrioxBio Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global cluster headache market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cluster headache market
Detailed Segmentation-
- By Type
- Episodic
- Chronic
- By Drug Type
- Fast-acting Drugs
- Long-term Drugs
- Short-term Drugs
- By Route of Administration
- Oral
- Topical
- Intravenous
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Autonomic Technologies, Inc.
- Epic Systems Corporation
- AstraZeneca
- ElectroCore, Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- W. L. Gore & Associates, Inc.
- Zosano Pharma
- Allergan, plc
- Amgen Inc.
- Biohaven Pharmaceutical Holding Company Ltd.
- Cefaly Technology
- Eliem Therapeutics, Inc.
- Lundbeck Seattle BioPharmaceuticals, Inc.
- Prismic Pharmaceuticals, Inc.
- Sanofi
- Upsher-Smith Laboratories, LLC
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Drug Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Cluster Headache Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Cluster Headache Market, By Type, 2020 - 2032, (USD Mn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Episodic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Chronic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Cluster Headache Market, By Drug Type, 2020 - 2032, (USD Mn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Fast-acting Drug
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Long-term Drugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Short-term Drugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global Cluster Headache Market, By Route of Administration, 2020 - 2032, (USD Mn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Topical
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Intravenous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
8. Global Cluster Headache Market, By Distribution Channel, 2020 - 2032, (USD Mn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
9. Global Cluster Headache Market, By Region, 2020 - 2032, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Autonomic Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Epic Systems Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ElectroCore, Inc.
- Eli Lilly and Company
- Hoffmann-La Roche Ltd
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- W.L. Gore & Associates, Inc.
- Zosano Pharma
- Allergan, plc
- Amgen Inc.
- Biohaven Pharmaceutical Holding Company Ltd.
- Cefaly Technology
- Eliem Therapeutics, Inc.
- Lundbeck Seattle BioPharmaceuticals, Inc.
- Prismic Pharmaceuticals, Inc.
- Sanofi
- Upsher-Smith Laboratories, LLC
- Autonomic Technologies, Inc.
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
